TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05457530

Doravirine and Weight Gain in Antiretroviral Naive

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Due to No/Low enrollment”

The sponsor’s own words in the registry.

Life of this trial

202220232024Registered2022-04-15Planned start2022-08-01 (planned)Withdrawn (as of)2023-05-12

Vital statistics

Status
Withdrawn
Phase
Phase 3
Sponsor
Prism Health North Texas
Sponsor type
University, hospital or other
Conditions
Body Weight Changes; Human Immunodeficiency Virus; ART; Obesity; Minority Health; BMD
Interventions
DOR/3TC/TDF; DOR + FTC/TAF; BIC/FTC/TAF
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.